Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient
7.7.2026 05:00:00 EEST | Business Wire | Press release
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy and functional ingredient company, today announced that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status in the United States for LAC-Living+™ (L. helveticus MCC1848), its proprietary postbiotic ingredient. This milestone expands the commercial availability of LAC-Living+ in the U.S. market and enables its use in dietary supplements, functional foods, and beverages, supporting the development of products designed to address growing consumer demand for health and well-being solutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706806943/en/
Growing Interest in Postbiotics and Mental Well-Being
Consumer interest in proactive health management has expanded significantly in recent years, alongside increasing awareness of the connection between the gut and the brain, commonly referred to as the gut–brain axis. As a result, the global functional ingredient market is evolving beyond conventional probiotics to include postbiotics—non-viable microorganisms and/or their components that offer physiological benefits. Postbiotics are gaining attention due to their stability, safety, and ease of formulation, particularly in product formats that are challenging for live microorganisms. These advantages make them an attractive option for manufacturers seeking reliable, science-based ingredients.
Morinaga Milk has been at the forefront of postbiotic research and development. In 2018, the company achieved self-affirmed GRAS status for LAC-Shield™ (L. paracasei MCC1849), its first postbiotic ingredient. Building on this experience, LAC-Living+™ represents the company’s second postbiotic innovation, developed to address emerging consumer needs in the area of mood and mental well-being.
LAC-Living+™: Clinical Evidence Supporting Everyday Well-Being
LAC-Living+™ (L. helveticus MCC1848) is a heat-treated postbiotic ingredient developed to combine scientific credibility with formulation flexibility. Its functionality has been evaluated in human clinical studies, which suggest that supplementation with LAC-Living+ may help support mental well-being and quality of life, particularly in individuals experiencing everyday stress. Reported outcomes have included improvements in indicators related to mood and psychological state, providing a scientific basis for its application in products targeting mental wellness. In Japan, L. helveticus MCC1848 has also been accepted as a functional ingredient under the Foods with Function Claims (FFC) system, with reported functionality to help maintain a positive mood (vitality) in situations involving temporary mental stress. While research into the gut–brain axis continues to evolve, such findings and achievements are contributing to a growing body of evidence supporting the role of microbiome-related ingredients in holistic health approaches that integrate physical and mental well-being.
Formulation Advantages for Broad Applications
In addition to its scientific foundation, LAC-Living+™ offers important technical advantages for product development.
As a postbiotic ingredient, LAC-Living+™ is non-viable, which allows it to maintain stability under conditions that may compromise live microorganisms. This includes exposure to heat processing, moisture, and extended shelf-life environments, making it suitable for a wide variety of applications. These characteristics provide manufacturers with greater flexibility in formulation and product design, supporting its use across categories such as ready-to-drink beverages, powders, bars, gummies, dairy products, and supplements.
Supporting Innovation in the U.S. Market
The attainment of self-affirmed GRAS status represents a key step in enabling broader adoption of LAC-Living+™ in the United States.
“Achieving self-affirmed GRAS status for LAC-Living+™ marks an important milestone for our postbiotic portfolio,” said Masashi Kamiya, General Manager of Functional Food Ingredients Division at Morinaga Milk Industry Co., Ltd. “With increasing interest in mental well-being and convenient health solutions, we believe LAC-Living+™ offers strong potential to support our partners in developing innovative products tailored to evolving consumer needs.”
Morinaga Milk remains committed to advancing its research and ingredient development efforts, with a focus on delivering safe, scientifically supported, and application-friendly solutions to the global market.
About Morinaga Milk Industry Co., Ltd.
Morinaga Milk Industry Co., Ltd. is one of Japan’s leading dairy companies, with more than 100 years of experience in harnessing the nutritional value of dairy and functional ingredients.
The company is recognized globally for its expertise in probiotics, postbiotics, and microbiome-related research, supported by decades of scientific investigation into the safety, functionality, and mechanisms of action of beneficial microorganisms. Since the 1960s, Morinaga Milk has been advancing research into bifidobacteria and their role in human health, contributing to the development of high-quality, science-based solutions for a wide range of applications.
For more information about Morinaga probiotics and postbiotics, please visit: https://morinagamilk-ingredients.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20260706806943/en/
Contacts
Morinaga Milk Industry Co., Ltd.
Investor& Public Relations Department: Kazuaki Kajikawa
Functional Food Ingredients Division: Saki Yamashita
E-mail:interntl-pr@morinagamilk.co.jp
Morinaga Milk website: https://www.morinagamilk.co.jp/english/ -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.morinagami
lk.co.jp%2Fenglish%2F&esheet=54565568&newsitemid=20260706806943&lan=en-US&anchor
=https%3A%2F%2Fwww.morinagamilk.co.jp%2Fenglish%2F&index=2&md5=99286906205e029ef
a334bb310456c04
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Access Advance Welcomes New Licensors to the Video Distribution Patent Pool7.7.2026 03:00:00 EEST | Press release
Access Advance LLC today announced that Sharp, M&K Holdings, Tagivan and 9 other patent owners who own substantial video codec patent portfolios that cover the core technologies behind video decoding, processing, and streaming media delivery, have joined the Video Distribution Patent Pool (VDP Pool) in the first half of 2026. "The addition of all of these new Licensors’ patent portfolios is a real win for both the VDP Pool and our many existing and future Licensees,” said Peter Moller, CEO of Access Advance. “These companies have broad and deep patent portfolios and further enhance the program’s market leading position in resolving the licensing issues around the use of modern video codecs across all the diverse business models of internet video streaming.” The following patent holders have joined the VDP Pool as Licensors in the first half of 2026: Digital Insights Inc. Hanbat National University Industry-Academic Cooperation Foundation Hanwha Vision Co., Ltd. Industry-Academy Coopera
Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 02:00:00 EEST | Press release
Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Kath Harrison, Group President, International Growth at Real Chemistry. “By bringing Spurwing into Real Chemistry,
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 23:04:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately $8.8 billion net of estimated cash acquired. The transaction was unanimously approved by both the Vertex and Crinetics Boards of Directors and is anticipated to close in the third quarter of 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706876183/en/ Crinetics’ marketed medicine, PALSONIFY® (paltusotine), received approval from the U.S. Food and Drug Administration (FDA) in September 2025. PALSONIFY was recently approved by the European Medicines Agency (EMA) a
Ciauru Wins the Second Edition of the Reply AI Music Contest, the International Competition Dedicated to Experimentation Across AI, Music and Live Performance6.7.2026 21:30:00 EEST | Press release
The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706007611/en/ The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival First place went to Ciauru, the stage name of Simone Privitera, an Italian multi-platinum DJ and producer who integrates artificial intelligence tools into a musical practice rooted in the contemporary electronic scene. With a career that has seen him collaborate wit
Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 20266.7.2026 16:00:00 EEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced it will report earnings after market close on July 30, 2026. The company will host a conference call and webcast on that date to discuss the second quarter 2026 results and the second half 2026 outlook at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706560476/en/ Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 2026 A live webcast of the event will be available on Rimini Street’s Investor Relations site via the Rimini Street IR events link and directly via the webcast link. Dial-in participants can access the conference by dialing 1-800-836-8184. A replay of the webcast will be available for one year following the event. About Rimini Street, Inc. Rimini Street, Inc. (Nasda
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom